Drug-tolerant persister cells in cancer: the cutting edges and future directions
Y Pu, L Li, H Peng, L Liu, D Heymann… - Nature Reviews …, 2023 - nature.com
Drug-tolerant persister (DTP) cell populations were originally discovered in antibiotic-
resistant bacterial biofilms. Similar populations with comparable features have since been …
resistant bacterial biofilms. Similar populations with comparable features have since been …
[HTML][HTML] Extracellular vesicle-based liquid biopsy biomarkers and their application in precision immuno-oncology
K Asleh, V Dery, C Taylor, M Davey… - Biomarker …, 2023 - Springer
While the field of precision oncology is rapidly expanding and more targeted options are
revolutionizing cancer treatment paradigms, therapeutic resistance particularly to …
revolutionizing cancer treatment paradigms, therapeutic resistance particularly to …
FINDER: A Fluidly Confined CRISPR‐Based DNA Reporter on Living Cell Membranes for Rapid and Sensitive Cancer Cell Identification
Y Yin, W Xie, M Xiong, Y Gao, Q Liu… - Angewandte Chemie …, 2023 - Wiley Online Library
The accurate, rapid, and sensitive identification of cancer cells in complex physiological
environments is significant in biological studies, personalized medicine, and biomedical …
environments is significant in biological studies, personalized medicine, and biomedical …
[HTML][HTML] Circulating tumor cells as liquid biopsy markers in cancer patients
Over the past decade, novel methods for enrichment and identification of cancer cells
circulating in the blood have been established. Blood-based detection of cancer cells and …
circulating in the blood have been established. Blood-based detection of cancer cells and …
Beyond blood: Advancing the frontiers of liquid biopsy in oncology and personalized medicine
Y Bao, D Zhang, H Guo, W Ma - Cancer Science, 2024 - Wiley Online Library
Liquid biopsy is emerging as a pivotal tool in precision oncology, offering a noninvasive and
comprehensive approach to cancer diagnostics and management. By harnessing biofluids …
comprehensive approach to cancer diagnostics and management. By harnessing biofluids …
[HTML][HTML] miRNAs in pancreatic cancer progression and metastasis
Small non-coding RNA or microRNA (miRNA) are critical regulators of eukaryotic cells.
Dysregulation of miRNA expression and function has been linked to a variety of diseases …
Dysregulation of miRNA expression and function has been linked to a variety of diseases …
Circulating tumor cells: from basic to translational research
LE Cortés-Hernández, Z Eslami-S, K Pantel… - Clinical …, 2024 - academic.oup.com
Background Metastasis is the leading cause of cancer-related deaths. Most studies have
focused on the primary tumor or on overt metastatic lesions, leaving a significant knowledge …
focused on the primary tumor or on overt metastatic lesions, leaving a significant knowledge …
Employing nano-enabled artificial intelligence (AI)-based smart technologies for prediction, screening, and detection of cancer
Cancer has been classified as a diverse illness with a wide range of subgroups. Its early
identification and prognosis, which have become a requirement of cancer research, are …
identification and prognosis, which have become a requirement of cancer research, are …
Unraveling the tumor microenvironment: insights into cancer metastasis and therapeutic strategies
This comprehensive review delves into the pivotal role of the tumor microenvironment (TME)
in cancer metastasis and therapeutic response, offering fresh insights into the intricate …
in cancer metastasis and therapeutic response, offering fresh insights into the intricate …
A Molecular Voyage: Multiomics Insights into Circulating Tumor Cells
YW Zhang, A Gvozdenovic, N Aceto - Cancer Discovery, 2024 - AACR
Circulating tumor cells (CTCs) play a pivotal role in metastasis, the leading cause of cancer-
associated death. Recent improvements of CTC isolation tools, coupled with a steady …
associated death. Recent improvements of CTC isolation tools, coupled with a steady …